These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 33894020)

  • 21. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.
    Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S
    Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schistosoma mansoni infection and socio-behavioural predictors of HIV risk: a cross-sectional study in women from Uganda.
    Yegorov S; Galiwango RM; Good SV; Mpendo J; Tannich E; Boggild AK; Kiwanuka N; Bagaya BS; Kaul R
    BMC Infect Dis; 2018 Nov; 18(1):586. PubMed ID: 30453907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of sex work with reduced activation of the mucosal immune system.
    Lajoie J; Kimani M; Plummer FA; Nyamiobo F; Kaul R; Kimani J; Fowke KR
    J Infect Dis; 2014 Jul; 210(2):319-29. PubMed ID: 24421257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant Imbalances of Systemic and Mucosal Immunity Increase HIV Acquisition Risk.
    Morrison CS; Chen PL; Yamamoto H; Gao X; Chipato T; Anderson S; Barbieri R; Salata R; Doncel GF; Fichorova RN
    J Acquir Immune Defic Syndr; 2020 May; 84(1):85-91. PubMed ID: 31985699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa.
    Dunkle KL; Jewkes RK; Brown HC; Gray GE; McIntryre JA; Harlow SD
    Lancet; 2004 May; 363(9419):1415-21. PubMed ID: 15121402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel.
    Keller MJ; Madan RP; Torres NM; Fazzari MJ; Cho S; Kalyoussef S; Shust G; Mesquita PM; Louissaint N; Chen J; Cohen HW; Diament EC; Lee AC; Soto-Torres L; Hendrix CW; Herold BC
    PLoS One; 2011 Jan; 6(1):e16475. PubMed ID: 21283552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal Assessment of Systemic and Genital Tract Inflammatory Markers and Endogenous Genital Tract E. coli Inhibitory Activity in HIV-Infected and Uninfected Women.
    Keller MJ; McGinn AP; Lo Y; Huber A; Espinoza L; Minkoff H; Colie C; Nowicki MJ; D'Souza G; Anastos K
    Am J Reprod Immunol; 2016 Jun; 75(6):631-42. PubMed ID: 27145926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sexual Risk Behavior, Sexual Violence, and HIV in Persons With Severe Mental Illness in Uganda: Hospital-Based Cross-Sectional Study and National Comparison Data.
    Lundberg P; Nakasujja N; Musisi S; Thorson AE; Cantor-Graae E; Allebeck P
    Am J Public Health; 2015 Jun; 105(6):1142-8. PubMed ID: 25880958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: a pilot study.
    Sperling R; Kraus TA; Ding J; Veretennikova A; Lorde-Rollins E; Singh T; Lo Y; Quayle AJ; Chang TL
    J Reprod Immunol; 2013 Sep; 99(1-2):80-7. PubMed ID: 23993451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Mucosal Markers of Human Immunodeficiency Virus Susceptibility in Healthy Premenopausal Versus Postmenopausal Women.
    Thurman AR; Yousefieh N; Chandra N; Kimble T; Asin S; Rollenhagen C; Anderson SM; Herold BC; Freiermuth JL; Starkman BS; Mesquita PMM; Richardson-Harman N; Cunningham T; Hillier S; Rabe L; Schwartz JL; Doncel GF
    AIDS Res Hum Retroviruses; 2017 Aug; 33(8):807-819. PubMed ID: 28398069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sexual minority status and violence among HIV infected and at-risk women.
    Pyra M; Weber K; Wilson TE; Cohen J; Murchison L; Goparaju L; Cohen MH
    J Gen Intern Med; 2014 Aug; 29(8):1131-8. PubMed ID: 24700180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sexual violence from police and HIV risk behaviours among HIV-positive women who inject drugs in St. Petersburg, Russia - a mixed methods study.
    Lunze K; Raj A; Cheng DM; Quinn EK; Lunze FI; Liebschutz JM; Bridden C; Walley AY; Blokhina E; Krupitsky E; Samet JH
    J Int AIDS Soc; 2016; 19(4 Suppl 3):20877. PubMed ID: 27435712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline variation and associations between subject characteristics and five cytokine biomarkers of vaginal safety among healthy non-pregnant women in microbicide trials.
    Fichorova RN; Lai JJ; Schwartz JL; Weiner DH; Mauck CK; Callahan MM
    Cytokine; 2011 Jul; 55(1):134-40. PubMed ID: 21530305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender inequity norms are associated with increased male-perpetrated rape and sexual risks for HIV infection in Botswana and Swaziland.
    Shannon K; Leiter K; Phaladze N; Hlanze Z; Tsai AC; Heisler M; Iacopino V; Weiser SD
    PLoS One; 2012; 7(1):e28739. PubMed ID: 22247761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women.
    Garrett N; Mtshali A; Osman F; Masson L; McKinnon LR; Singh R; Mitchev N; Ngobese H; Kharsany ABM; Abdool Karim S; Mlisana K; Passmore JA; Rompalo A; Mindel A; Liebenberg L
    Sex Transm Infect; 2021 Dec; 97(8):555-565. PubMed ID: 33608480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal serpin A1 and A3 levels in HIV highly exposed sero-negative women are affected by the menstrual cycle and hormonal contraceptives but are independent of epidemiological confounders.
    Rahman S; Rabbani R; Wachihi C; Kimani J; Plummer FA; Ball TB; Burgener A
    Am J Reprod Immunol; 2013 Jan; 69(1):64-72. PubMed ID: 22971020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral activity of genital tract secretions after oral or topical tenofovir pre-exposure prophylaxis for HIV-1.
    Herold BC; Dezzutti CS; Richardson BA; Marrazzo J; Mesquita PM; Carpenter C; Huber A; Louissaint N; Marzinke MA; Hillier SL; Hendrix CW
    J Acquir Immune Defic Syndr; 2014 May; 66(1):65-73. PubMed ID: 24457633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intimate partner violence among women with HIV infection in rural Uganda: critical implications for policy and practice.
    Osinde MO; Kaye DK; Kakaire O
    BMC Womens Health; 2011 Nov; 11():50. PubMed ID: 22093904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher levels of cervicovaginal inflammatory and regulatory cytokines and chemokines in healthy young women with immature cervical epithelium.
    Hwang LY; Scott ME; Ma Y; Moscicki AB
    J Reprod Immunol; 2011 Jan; 88(1):66-71. PubMed ID: 21051089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of a culturally appropriate intervention to prevent intimate partner violence and HIV transmission among men, women, and couples in rural Ethiopia: Findings from a cluster-randomized controlled trial.
    Sharma V; Leight J; Verani F; Tewolde S; Deyessa N
    PLoS Med; 2020 Aug; 17(8):e1003274. PubMed ID: 32810146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.